UNITED CAPITAL FINANCIAL ADVISORS, LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 319 filers reported holding NOVOCURE LTD in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
UNITED CAPITAL FINANCIAL ADVISORS, LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q4 2022$1,109,346
+82.5%
15,124
+89.1%
0.01%
+50.0%
Q3 2022$608,000
+8.4%
7,998
-0.9%
0.00%
+33.3%
Q2 2022$561,000
-14.4%
8,072
+2.2%
0.00%0.0%
Q1 2022$655,000
+16.8%
7,900
+5.7%
0.00%0.0%
Q4 2021$561,000
-35.4%
7,4750.0%0.00%
-25.0%
Q3 2021$868,000
-47.7%
7,475
-0.1%
0.00%
-50.0%
Q2 2021$1,659,000
+67.9%
7,480
+0.1%
0.01%
+60.0%
Q1 2021$988,000
-23.8%
7,476
-0.1%
0.01%
-37.5%
Q4 2020$1,296,000
+56.0%
7,487
+0.2%
0.01%
+60.0%
Q3 2020$831,000
+73.8%
7,469
-7.4%
0.01%
+66.7%
Q2 2020$478,000
-5.0%
8,069
+8.0%
0.00%
-25.0%
Q1 2020$503,000
-19.9%
7,469
+0.1%
0.00%0.0%
Q4 2019$628,000
+12.5%
7,4580.0%0.00%0.0%
Q3 2019$558,000
+19.2%
7,458
+0.8%
0.00%
+33.3%
Q2 2019$468,000
+33.0%
7,399
+1.2%
0.00%
+50.0%
Q1 2019$352,000
+43.7%
7,3120.0%0.00%0.0%
Q4 2018$245,000
-45.4%
7,312
-14.7%
0.00%
-33.3%
Q3 2018$449,000
+72.7%
8,575
+3.2%
0.00%
+50.0%
Q2 2018$260,0008,3120.00%
Other shareholders
NOVOCURE LTD shareholders Q3 2021
NameSharesValueWeighting ↓
Nordwand Advisors, LLC 1,515,000$111,125,24913.86%
Invus Financial Advisors, LLC 350,884$25,737,34113.70%
HARTLINE INVESTMENT CORP/ 304,482$22,333,7555.08%
GREAT POINT PARTNERS LLC 241,000$17,677,3503.46%
Tri Locum Partners LP 72,400$5,311,0002.15%
Taylor Frigon Capital Management LLC 42,061$3,085,1741.75%
HighVista Strategies LLC 28,007$2,054,3131.22%
HAP Trading, LLC 124,500$10,2941.05%
Private Harbour Investment Management & Counsel, LLC 12,285$901,1050.99%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 32,000$2,344,0000.72%
View complete list of NOVOCURE LTD shareholders